カテゴリー： 世界, 医療/バイオ, LP Information

世界の一般外科用止血剤市場予測 2023年-2029年

【英語タイトル】Global General Surgery Hemostatic Agents Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4776）・商品コード：LP23MY4776
・発行会社（調査会社）：LP Information
・発行日：2023年5月
・ページ数：98
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の一般外科用止血剤市場」は、過去の販売実績から2022年の世界の一般外科用止血剤の総販売量を検討し、2023年から2029年の予測される一般外科用止血剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の一般外科用止血剤の市場規模を掲載し、XXX百万米ドル規模の世界の一般外科用止血剤市場の詳細な分析を提供します。本インサイトレポートは、世界の一般外科用止血剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の一般外科用止血剤市場における各社の独自のポジションをより深く理解するために、一般外科用止血剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の一般外科用止血剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。一般外科用止血剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。一般外科用止血剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。一般外科用止血剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

一般外科用止血剤の世界主要メーカーとしては、B. Braun、 ENDOVISION、 Ethicon、 Meril Life Sciences、 CryoLife、 Team Consulting、 HONG KONG MEDIなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の一般外科用止血剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では一般外科用止血剤市場をセグメンテーションし、種類別 (止血パッド、止血パウダー、ニットストリップ止血剤、止血ジェル、その他)、用途別 (病院、診療所、治療センター、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：止血パッド、止血パウダー、ニットストリップ止血剤、止血ジェル、その他

・用途別区分：病院、診療所、治療センター、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の一般外科用止血剤市場の10年間の市場状況・展望は？
・世界および地域別に見た一般外科用止血剤市場成長の要因は何か？
・一般外科用止血剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・一般外科用止血剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：一般外科用止血剤の年間販売量2018-2029、地域別現状・将来分析
・一般外科用止血剤の種類別セグメント：止血パッド、止血パウダー、ニットストリップ止血剤、止血ジェル、その他
・一般外科用止血剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・一般外科用止血剤の用途別セグメント：病院、診療所、治療センター、その他
・一般外科用止血剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の一般外科用止血剤市場
・企業別のグローバル一般外科用止血剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別の一般外科用止血剤の年間売上：2018-2023年の売上、市場シェア
・企業別の一般外科用止血剤販売価格
・主要企業の一般外科用止血剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

一般外科用止血剤の地域別レビュー
・地域別の一般外科用止血剤市場規模2018-2023：年間販売量、売上
・主要国別の一般外科用止血剤市場規模2018-2023：年間販売量、売上
・南北アメリカの一般外科用止血剤販売の成長
・アジア太平洋の一般外科用止血剤販売の成長
・ヨーロッパの一般外科用止血剤販売の成長
・中東・アフリカの一般外科用止血剤販売の成長

南北アメリカ市場
・南北アメリカの国別の一般外科用止血剤販売量、売上（2018-2023）
・南北アメリカの一般外科用止血剤の種類別販売量
・南北アメリカの一般外科用止血剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の一般外科用止血剤販売量、売上（2018-2023）
・アジア太平洋の一般外科用止血剤の種類別販売量
・アジア太平洋の一般外科用止血剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の一般外科用止血剤販売量、売上（2018-2023）
・ヨーロッパの一般外科用止血剤の種類別販売量
・ヨーロッパの一般外科用止血剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の一般外科用止血剤販売量、売上（2018-2023）
・中東・アフリカの一般外科用止血剤の種類別販売量
・中東・アフリカの一般外科用止血剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・一般外科用止血剤の製造コスト構造分析
・一般外科用止血剤の製造プロセス分析
・一般外科用止血剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・一般外科用止血剤の主要なグローバル販売業者
・一般外科用止血剤の主要なグローバル顧客

地域別の一般外科用止血剤市場予測レビュー
・地域別の一般外科用止血剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・一般外科用止血剤の種類別市場規模予測
・一般外科用止血剤の用途別市場規模予測

主要企業分析
B. Braun、 ENDOVISION、 Ethicon、 Meril Life Sciences、 CryoLife、 Team Consulting、 HONG KONG MEDI
・企業情報
・一般外科用止血剤製品
・一般外科用止血剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

General Surgery Hemostatic Agents improve hemostasis by improving the initial hemostatic process, stimulating fibrin formation, or inhibiting fibrinolysis.
LPI (LP Information)’ newest research report, the “General Surgery Hemostatic Agents Industry Forecast” looks at past sales and reviews total world General Surgery Hemostatic Agents sales in 2022, providing a comprehensive analysis by region and market sector of projected General Surgery Hemostatic Agents sales for 2023 through 2029. With General Surgery Hemostatic Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world General Surgery Hemostatic Agents industry.
This Insight Report provides a comprehensive analysis of the global General Surgery Hemostatic Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on General Surgery Hemostatic Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global General Surgery Hemostatic Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for General Surgery Hemostatic Agents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global General Surgery Hemostatic Agents.
The global General Surgery Hemostatic Agents market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for General Surgery Hemostatic Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for General Surgery Hemostatic Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for General Surgery Hemostatic Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key General Surgery Hemostatic Agents players cover B. Braun, ENDOVISION, Ethicon, Meril Life Sciences, CryoLife, Team Consulting and HONG KONG MEDI, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of General Surgery Hemostatic Agents market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Hemostatic Pad
Hemostatic Powder
Hemostatic Knitted Strip
Hemostatic Gel
Others
Segmentation by application
Hospital
Clinic
Care Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
B. Braun
ENDOVISION
Ethicon
Meril Life Sciences
CryoLife
Team Consulting
HONG KONG MEDI
Key Questions Addressed in this Report
What is the 10-year outlook for the global General Surgery Hemostatic Agents market?
What factors are driving General Surgery Hemostatic Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do General Surgery Hemostatic Agents market opportunities vary by end market size?
How does General Surgery Hemostatic Agents break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global General Surgery Hemostatic Agents Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for General Surgery Hemostatic Agents by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for General Surgery Hemostatic Agents by Country/Region, 2018, 2022 & 2029
2.2 General Surgery Hemostatic Agents Segment by Type
2.2.1 Hemostatic Pad
2.2.2 Hemostatic Powder
2.2.3 Hemostatic Knitted Strip
2.2.4 Hemostatic Gel
2.2.5 Others
2.3 General Surgery Hemostatic Agents Sales by Type
2.3.1 Global General Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
2.3.2 Global General Surgery Hemostatic Agents Revenue and Market Share by Type (2018-2023)
2.3.3 Global General Surgery Hemostatic Agents Sale Price by Type (2018-2023)
2.4 General Surgery Hemostatic Agents Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Care Center
2.4.4 Others
2.5 General Surgery Hemostatic Agents Sales by Application
2.5.1 Global General Surgery Hemostatic Agents Sale Market Share by Application (2018-2023)
2.5.2 Global General Surgery Hemostatic Agents Revenue and Market Share by Application (2018-2023)
2.5.3 Global General Surgery Hemostatic Agents Sale Price by Application (2018-2023)
3 Global General Surgery Hemostatic Agents by Company
3.1 Global General Surgery Hemostatic Agents Breakdown Data by Company
3.1.1 Global General Surgery Hemostatic Agents Annual Sales by Company (2018-2023)
3.1.2 Global General Surgery Hemostatic Agents Sales Market Share by Company (2018-2023)
3.2 Global General Surgery Hemostatic Agents Annual Revenue by Company (2018-2023)
3.2.1 Global General Surgery Hemostatic Agents Revenue by Company (2018-2023)
3.2.2 Global General Surgery Hemostatic Agents Revenue Market Share by Company (2018-2023)
3.3 Global General Surgery Hemostatic Agents Sale Price by Company
3.4 Key Manufacturers General Surgery Hemostatic Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers General Surgery Hemostatic Agents Product Location Distribution
3.4.2 Players General Surgery Hemostatic Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for General Surgery Hemostatic Agents by Geographic Region
4.1 World Historic General Surgery Hemostatic Agents Market Size by Geographic Region (2018-2023)
4.1.1 Global General Surgery Hemostatic Agents Annual Sales by Geographic Region (2018-2023)
4.1.2 Global General Surgery Hemostatic Agents Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic General Surgery Hemostatic Agents Market Size by Country/Region (2018-2023)
4.2.1 Global General Surgery Hemostatic Agents Annual Sales by Country/Region (2018-2023)
4.2.2 Global General Surgery Hemostatic Agents Annual Revenue by Country/Region (2018-2023)
4.3 Americas General Surgery Hemostatic Agents Sales Growth
4.4 APAC General Surgery Hemostatic Agents Sales Growth
4.5 Europe General Surgery Hemostatic Agents Sales Growth
4.6 Middle East & Africa General Surgery Hemostatic Agents Sales Growth
5 Americas
5.1 Americas General Surgery Hemostatic Agents Sales by Country
5.1.1 Americas General Surgery Hemostatic Agents Sales by Country (2018-2023)
5.1.2 Americas General Surgery Hemostatic Agents Revenue by Country (2018-2023)
5.2 Americas General Surgery Hemostatic Agents Sales by Type
5.3 Americas General Surgery Hemostatic Agents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC General Surgery Hemostatic Agents Sales by Region
6.1.1 APAC General Surgery Hemostatic Agents Sales by Region (2018-2023)
6.1.2 APAC General Surgery Hemostatic Agents Revenue by Region (2018-2023)
6.2 APAC General Surgery Hemostatic Agents Sales by Type
6.3 APAC General Surgery Hemostatic Agents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe General Surgery Hemostatic Agents by Country
7.1.1 Europe General Surgery Hemostatic Agents Sales by Country (2018-2023)
7.1.2 Europe General Surgery Hemostatic Agents Revenue by Country (2018-2023)
7.2 Europe General Surgery Hemostatic Agents Sales by Type
7.3 Europe General Surgery Hemostatic Agents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa General Surgery Hemostatic Agents by Country
8.1.1 Middle East & Africa General Surgery Hemostatic Agents Sales by Country (2018-2023)
8.1.2 Middle East & Africa General Surgery Hemostatic Agents Revenue by Country (2018-2023)
8.2 Middle East & Africa General Surgery Hemostatic Agents Sales by Type
8.3 Middle East & Africa General Surgery Hemostatic Agents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of General Surgery Hemostatic Agents
10.3 Manufacturing Process Analysis of General Surgery Hemostatic Agents
10.4 Industry Chain Structure of General Surgery Hemostatic Agents
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 General Surgery Hemostatic Agents Distributors
11.3 General Surgery Hemostatic Agents Customer
12 World Forecast Review for General Surgery Hemostatic Agents by Geographic Region
12.1 Global General Surgery Hemostatic Agents Market Size Forecast by Region
12.1.1 Global General Surgery Hemostatic Agents Forecast by Region (2024-2029)
12.1.2 Global General Surgery Hemostatic Agents Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global General Surgery Hemostatic Agents Forecast by Type
12.7 Global General Surgery Hemostatic Agents Forecast by Application
13 Key Players Analysis
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun General Surgery Hemostatic Agents Product Portfolios and Specifications
13.1.3 B. Braun General Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 ENDOVISION
13.2.1 ENDOVISION Company Information
13.2.2 ENDOVISION General Surgery Hemostatic Agents Product Portfolios and Specifications
13.2.3 ENDOVISION General Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 ENDOVISION Main Business Overview
13.2.5 ENDOVISION Latest Developments
13.3 Ethicon
13.3.1 Ethicon Company Information
13.3.2 Ethicon General Surgery Hemostatic Agents Product Portfolios and Specifications
13.3.3 Ethicon General Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ethicon Main Business Overview
13.3.5 Ethicon Latest Developments
13.4 Meril Life Sciences
13.4.1 Meril Life Sciences Company Information
13.4.2 Meril Life Sciences General Surgery Hemostatic Agents Product Portfolios and Specifications
13.4.3 Meril Life Sciences General Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Meril Life Sciences Main Business Overview
13.4.5 Meril Life Sciences Latest Developments
13.5 CryoLife
13.5.1 CryoLife Company Information
13.5.2 CryoLife General Surgery Hemostatic Agents Product Portfolios and Specifications
13.5.3 CryoLife General Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CryoLife Main Business Overview
13.5.5 CryoLife Latest Developments
13.6 Team Consulting
13.6.1 Team Consulting Company Information
13.6.2 Team Consulting General Surgery Hemostatic Agents Product Portfolios and Specifications
13.6.3 Team Consulting General Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Team Consulting Main Business Overview
13.6.5 Team Consulting Latest Developments
13.7 HONG KONG MEDI
13.7.1 HONG KONG MEDI Company Information
13.7.2 HONG KONG MEDI General Surgery Hemostatic Agents Product Portfolios and Specifications
13.7.3 HONG KONG MEDI General Surgery Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 HONG KONG MEDI Main Business Overview
13.7.5 HONG KONG MEDI Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. General Surgery Hemostatic Agents Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. General Surgery Hemostatic Agents Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hemostatic Pad
Table 4. Major Players of Hemostatic Powder
Table 5. Major Players of Hemostatic Knitted Strip
Table 6. Major Players of Hemostatic Gel
Table 7. Major Players of Others
Table 8. Global General Surgery Hemostatic Agents Sales by Type (2018-2023) & (K Units)
Table 9. Global General Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
Table 10. Global General Surgery Hemostatic Agents Revenue by Type (2018-2023) & ($ million)
Table 11. Global General Surgery Hemostatic Agents Revenue Market Share by Type (2018-2023)
Table 12. Global General Surgery Hemostatic Agents Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global General Surgery Hemostatic Agents Sales by Application (2018-2023) & (K Units)
Table 14. Global General Surgery Hemostatic Agents Sales Market Share by Application (2018-2023)
Table 15. Global General Surgery Hemostatic Agents Revenue by Application (2018-2023)
Table 16. Global General Surgery Hemostatic Agents Revenue Market Share by Application (2018-2023)
Table 17. Global General Surgery Hemostatic Agents Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global General Surgery Hemostatic Agents Sales by Company (2018-2023) & (K Units)
Table 19. Global General Surgery Hemostatic Agents Sales Market Share by Company (2018-2023)
Table 20. Global General Surgery Hemostatic Agents Revenue by Company (2018-2023) ($ Millions)
Table 21. Global General Surgery Hemostatic Agents Revenue Market Share by Company (2018-2023)
Table 22. Global General Surgery Hemostatic Agents Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers General Surgery Hemostatic Agents Producing Area Distribution and Sales Area
Table 24. Players General Surgery Hemostatic Agents Products Offered
Table 25. General Surgery Hemostatic Agents Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global General Surgery Hemostatic Agents Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global General Surgery Hemostatic Agents Sales Market Share Geographic Region (2018-2023)
Table 30. Global General Surgery Hemostatic Agents Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global General Surgery Hemostatic Agents Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global General Surgery Hemostatic Agents Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global General Surgery Hemostatic Agents Sales Market Share by Country/Region (2018-2023)
Table 34. Global General Surgery Hemostatic Agents Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global General Surgery Hemostatic Agents Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas General Surgery Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 37. Americas General Surgery Hemostatic Agents Sales Market Share by Country (2018-2023)
Table 38. Americas General Surgery Hemostatic Agents Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas General Surgery Hemostatic Agents Revenue Market Share by Country (2018-2023)
Table 40. Americas General Surgery Hemostatic Agents Sales by Type (2018-2023) & (K Units)
Table 41. Americas General Surgery Hemostatic Agents Sales by Application (2018-2023) & (K Units)
Table 42. APAC General Surgery Hemostatic Agents Sales by Region (2018-2023) & (K Units)
Table 43. APAC General Surgery Hemostatic Agents Sales Market Share by Region (2018-2023)
Table 44. APAC General Surgery Hemostatic Agents Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC General Surgery Hemostatic Agents Revenue Market Share by Region (2018-2023)
Table 46. APAC General Surgery Hemostatic Agents Sales by Type (2018-2023) & (K Units)
Table 47. APAC General Surgery Hemostatic Agents Sales by Application (2018-2023) & (K Units)
Table 48. Europe General Surgery Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 49. Europe General Surgery Hemostatic Agents Sales Market Share by Country (2018-2023)
Table 50. Europe General Surgery Hemostatic Agents Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe General Surgery Hemostatic Agents Revenue Market Share by Country (2018-2023)
Table 52. Europe General Surgery Hemostatic Agents Sales by Type (2018-2023) & (K Units)
Table 53. Europe General Surgery Hemostatic Agents Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa General Surgery Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa General Surgery Hemostatic Agents Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa General Surgery Hemostatic Agents Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa General Surgery Hemostatic Agents Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa General Surgery Hemostatic Agents Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa General Surgery Hemostatic Agents Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of General Surgery Hemostatic Agents
Table 61. Key Market Challenges & Risks of General Surgery Hemostatic Agents
Table 62. Key Industry Trends of General Surgery Hemostatic Agents
Table 63. General Surgery Hemostatic Agents Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. General Surgery Hemostatic Agents Distributors List
Table 66. General Surgery Hemostatic Agents Customer List
Table 67. Global General Surgery Hemostatic Agents Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global General Surgery Hemostatic Agents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas General Surgery Hemostatic Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas General Surgery Hemostatic Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC General Surgery Hemostatic Agents Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC General Surgery Hemostatic Agents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe General Surgery Hemostatic Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe General Surgery Hemostatic Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa General Surgery Hemostatic Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa General Surgery Hemostatic Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global General Surgery Hemostatic Agents Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global General Surgery Hemostatic Agents Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global General Surgery Hemostatic Agents Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global General Surgery Hemostatic Agents Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. B. Braun Basic Information, General Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 82. B. Braun General Surgery Hemostatic Agents Product Portfolios and Specifications
Table 83. B. Braun General Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. B. Braun Main Business
Table 85. B. Braun Latest Developments
Table 86. ENDOVISION Basic Information, General Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 87. ENDOVISION General Surgery Hemostatic Agents Product Portfolios and Specifications
Table 88. ENDOVISION General Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. ENDOVISION Main Business
Table 90. ENDOVISION Latest Developments
Table 91. Ethicon Basic Information, General Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 92. Ethicon General Surgery Hemostatic Agents Product Portfolios and Specifications
Table 93. Ethicon General Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Ethicon Main Business
Table 95. Ethicon Latest Developments
Table 96. Meril Life Sciences Basic Information, General Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 97. Meril Life Sciences General Surgery Hemostatic Agents Product Portfolios and Specifications
Table 98. Meril Life Sciences General Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Meril Life Sciences Main Business
Table 100. Meril Life Sciences Latest Developments
Table 101. CryoLife Basic Information, General Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 102. CryoLife General Surgery Hemostatic Agents Product Portfolios and Specifications
Table 103. CryoLife General Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. CryoLife Main Business
Table 105. CryoLife Latest Developments
Table 106. Team Consulting Basic Information, General Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 107. Team Consulting General Surgery Hemostatic Agents Product Portfolios and Specifications
Table 108. Team Consulting General Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Team Consulting Main Business
Table 110. Team Consulting Latest Developments
Table 111. HONG KONG MEDI Basic Information, General Surgery Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 112. HONG KONG MEDI General Surgery Hemostatic Agents Product Portfolios and Specifications
Table 113. HONG KONG MEDI General Surgery Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. HONG KONG MEDI Main Business
Table 115. HONG KONG MEDI Latest Developments
List of Figures
Figure 1. Picture of General Surgery Hemostatic Agents
Figure 2. General Surgery Hemostatic Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global General Surgery Hemostatic Agents Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global General Surgery Hemostatic Agents Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. General Surgery Hemostatic Agents Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hemostatic Pad
Figure 10. Product Picture of Hemostatic Powder
Figure 11. Product Picture of Hemostatic Knitted Strip
Figure 12. Product Picture of Hemostatic Gel
Figure 13. Product Picture of Others
Figure 14. Global General Surgery Hemostatic Agents Sales Market Share by Type in 2022
Figure 15. Global General Surgery Hemostatic Agents Revenue Market Share by Type (2018-2023)
Figure 16. General Surgery Hemostatic Agents Consumed in Hospital
Figure 17. Global General Surgery Hemostatic Agents Market: Hospital (2018-2023) & (K Units)
Figure 18. General Surgery Hemostatic Agents Consumed in Clinic
Figure 19. Global General Surgery Hemostatic Agents Market: Clinic (2018-2023) & (K Units)
Figure 20. General Surgery Hemostatic Agents Consumed in Care Center
Figure 21. Global General Surgery Hemostatic Agents Market: Care Center (2018-2023) & (K Units)
Figure 22. General Surgery Hemostatic Agents Consumed in Others
Figure 23. Global General Surgery Hemostatic Agents Market: Others (2018-2023) & (K Units)
Figure 24. Global General Surgery Hemostatic Agents Sales Market Share by Application (2022)
Figure 25. Global General Surgery Hemostatic Agents Revenue Market Share by Application in 2022
Figure 26. General Surgery Hemostatic Agents Sales Market by Company in 2022 (K Units)
Figure 27. Global General Surgery Hemostatic Agents Sales Market Share by Company in 2022
Figure 28. General Surgery Hemostatic Agents Revenue Market by Company in 2022 ($ Million)
Figure 29. Global General Surgery Hemostatic Agents Revenue Market Share by Company in 2022
Figure 30. Global General Surgery Hemostatic Agents Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global General Surgery Hemostatic Agents Revenue Market Share by Geographic Region in 2022
Figure 32. Americas General Surgery Hemostatic Agents Sales 2018-2023 (K Units)
Figure 33. Americas General Surgery Hemostatic Agents Revenue 2018-2023 ($ Millions)
Figure 34. APAC General Surgery Hemostatic Agents Sales 2018-2023 (K Units)
Figure 35. APAC General Surgery Hemostatic Agents Revenue 2018-2023 ($ Millions)
Figure 36. Europe General Surgery Hemostatic Agents Sales 2018-2023 (K Units)
Figure 37. Europe General Surgery Hemostatic Agents Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa General Surgery Hemostatic Agents Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa General Surgery Hemostatic Agents Revenue 2018-2023 ($ Millions)
Figure 40. Americas General Surgery Hemostatic Agents Sales Market Share by Country in 2022
Figure 41. Americas General Surgery Hemostatic Agents Revenue Market Share by Country in 2022
Figure 42. Americas General Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
Figure 43. Americas General Surgery Hemostatic Agents Sales Market Share by Application (2018-2023)
Figure 44. United States General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC General Surgery Hemostatic Agents Sales Market Share by Region in 2022
Figure 49. APAC General Surgery Hemostatic Agents Revenue Market Share by Regions in 2022
Figure 50. APAC General Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
Figure 51. APAC General Surgery Hemostatic Agents Sales Market Share by Application (2018-2023)
Figure 52. China General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 56. India General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe General Surgery Hemostatic Agents Sales Market Share by Country in 2022
Figure 60. Europe General Surgery Hemostatic Agents Revenue Market Share by Country in 2022
Figure 61. Europe General Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
Figure 62. Europe General Surgery Hemostatic Agents Sales Market Share by Application (2018-2023)
Figure 63. Germany General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 64. France General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa General Surgery Hemostatic Agents Sales Market Share by Country in 2022
Figure 69. Middle East & Africa General Surgery Hemostatic Agents Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa General Surgery Hemostatic Agents Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa General Surgery Hemostatic Agents Sales Market Share by Application (2018-2023)
Figure 72. Egypt General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country General Surgery Hemostatic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of General Surgery Hemostatic Agents in 2022
Figure 78. Manufacturing Process Analysis of General Surgery Hemostatic Agents
Figure 79. Industry Chain Structure of General Surgery Hemostatic Agents
Figure 80. Channels of Distribution
Figure 81. Global General Surgery Hemostatic Agents Sales Market Forecast by Region (2024-2029)
Figure 82. Global General Surgery Hemostatic Agents Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global General Surgery Hemostatic Agents Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global General Surgery Hemostatic Agents Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global General Surgery Hemostatic Agents Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global General Surgery Hemostatic Agents Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の一般外科用止血剤市場予測 2023年-2029年] (コード：LP23MY4776)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の一般外科用止血剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の創傷手術用止血剤市場予測 2023年-2029年
  • 世界の歯科手術用止血パッド市場予測 2023年-2029年
  • 世界のENT（耳鼻咽喉科）手術用止血パッド市場予測 2023年-2029年
  • 世界の止血ジェル市場予測 2023年-2029年
  • 世界の止血剤＆組織シーリング剤市場予測 2023年-2029年
  • 世界の一般外科用縫合糸市場予測 2023年-2029年
  • 世界の血管手術用組織接着剤市場予測 2023年-2029年
  • 世界の歯科手術用レーザー市場予測 2023年-2029年
  • 世界の消化器外科用縫合糸市場予測 2023年-2029年
  • 世界の創傷手術用縫合糸市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆